Home TGF-beta/Smad -Epigenetics -Cytoskeletal Signaling PKC PKCγ Inhibitors

PKCγ Inhibitors

  • PKCα
  • PKCβ
  • PKCγ
  • PKCδ
  • PKCε
  • PKCζ
  • PKCη
  • PKCθ
  • PKCμ
Cat.No. 제품명 정보 선택적 / 팬 IC50 / Ki
S1421 Staurosporine Staurosporine is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM). Phase 3. Pan PKCγ, IC50: 5 nM
S2911 Go 6983 Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively; less potent to PKCζ and inactive to PKCμ. Pan PKCγ, IC50: 6 nM
S7208 GF109203X GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor. Pan PKCγ, IC50: 20 nM
S7207 Ro 31-8220 Mesylate Ro 31-8220 is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively, and also shows potent inhibition against MAPKAP-K1b, MSK1, GSK3β and S6K1. Pan PKCγ, IC50: 27 nM
S1055 Enzastaurin (LY317615) Enzastaurin (LY317615) is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε. Phase 3. Pan PKCγ, IC50: 83 nM